IDiyas

For the Inventor, By the Inventor

East Lyme, CT, United States of America

John Wing Wong

USPTO Granted Patents = 10

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal10 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 2001-2012

Loading Chart...
10 patents (USPTO):Explore Patents
1. 8304252 - Stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids (2012-11-06),
2. 7727749 - Stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids (2010-06-01),
3. 6919460 - Processes and intermediates useful in preparing β3-adrenergic receptor agonists (2005-07-19),
4. 6746856 - Microbial conversion of bicyclic heteroaromatic compounds (2004-06-08),
5. 6689888 - Processes and intermediates useful in preparing &bgr;3-adrenergic receptor agonists (2004-02-10),
6. 6613550 - Microbial process for preparation of optically active 3-hydroxypyrrolidine derivatives (2003-09-02),
7. 6589777 - Stereoselective microbial reduction of a racemic tetralone (2003-07-08),
8. 6451587 - Microbial asymmetric reduction of 2-chloro-1-[-6-(2,5-dimethyl-pyrrol-1-yl)-pyridin-3-yl]-ethanone (2002-09-17),
9. 6361979 - Microbial conversion of 2-methylquinoxaline (2002-03-26),
10. 6277860 - Furopyridine antibacterials (2001-08-21),

Title: Innovations of John Wing Wong

Introduction

John Wing Wong is a notable inventor based in East Lyme, Connecticut. He has made significant contributions to the field of biochemistry, particularly in the area of drug synthesis. With a total of 10 patents to his name, Wong's work has had a profound impact on medical treatments.

Latest Patents

One of Wong's latest patents focuses on the stereoselective bioconversion of aliphatic dinitriles into cyano carboxylic acids. This invention provides methods for converting 2-isobutyl-succinonitrile into (S)-3 cyano-5-methylhexanoic acid. This compound serves as a useful intermediate in the synthesis of (S)-3(aminomethyl)-5-methylhexanoic acid, commonly known as pregabalin. Pregabalin is utilized in treating various cerebral diseases, including seizure disorders, pain, and psychotic disorders.

Career Highlights

Wong's career is marked by his association with Pfizer Corporation, where he has been able to apply his innovative ideas in a corporate setting. His work has not only advanced scientific knowledge but has also contributed to the development of effective treatments for patients.

Collaborations

Wong has collaborated with several talented individuals, including Michael P. Burns and Justin K. Weaver. These collaborations have further enriched his research and development efforts.

Conclusion

John Wing Wong's contributions to the field of biochemistry and his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of important therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…